HIV

Illustration of a woman with depression symptoms overlaid with microscopic view of aging monocytes in blood, linking to study on women with and without HIV.

Study links monocyte “biological aging” in blood to emotional depression symptoms in women with and without HIV

4. mai 2026 Rapportert av AI Bilde generert av AI Faktasjekket

A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.

UNAIDS welcomes South Africa’s Lenacapavir HIV prevention launch

UNAIDS has welcomed South Africa’s rollout of Lenacapavir as a landmark step in HIV prevention. The injectable is now available at 360 public health facilities across six provinces. The drug has also been added to the national essential medicines list.

New HIV pill simplifies treatment for complex cases

1. juni 2026 Rapportert av AI

A new combination pill containing bictegravir and lenacapavir shows promise for people with HIV who require complex regimens. The phase three ARTISTRY 1 study found it performed as well as existing multi-pill options. Experts note its impact in South Africa will likely remain limited.

Helse

Low doses of THC show benefits for HIV treatment in animals

America

Gilead and Fiocruz sign agreement for HIV injection production in Brazil

America

Anvisa approves semiannual injection to prevent HIV

Madhya Pradesh suspends three officials in Satna hospital HIV case

Following a probe panel's preliminary findings, Madhya Pradesh has suspended the blood bank in-charge and two lab technicians at Satna's Sardar Vallabhbhai Patel Government Hospital, where six thalassemia children contracted HIV from infected blood transfusions. A show-cause notice was issued to the former civil surgeon.

Promising medical advances for 2026

17. desember 2025 Rapportert av AI

Nature Medicine has selected promising clinical studies for 2026, emphasizing long-lasting vaccines and innovative treatments. Key areas include tuberculosis, HIV, long Covid, stem cells, and cholesterol. These developments could transform the fight against global diseases.

US aid withdrawal impacts South Africa's HIV testing

The withdrawal of US aid since February 2025 has led to a significant drop in HIV viral load tests in South Africa, according to data from the National Health Laboratory Service. Public health experts warn this signals serious setbacks in the country's HIV management program. While viral rebound rates have decreased, the reasons remain unclear.

Global HIV Trends Show Continued Decline

13. september 2025 Rapportert av AI Faktasjekket

An NPR report on September 12, 2025, highlighted the ongoing retreat of HIV worldwide, with fewer deaths, decreasing infections, and increased access to life-saving medications. These positive trends have persisted for decades.

mandag, 18. mai 2026, 04:27